BioCentury
ARTICLE | Financial News

ConjuChem sells shoe

January 26, 2001 8:00 AM UTC

ConjuChem (TSE:CJC), which is using its in vivo bioconjugation technology to increase the therapeutic properties of existing drugs, raised C$3.8 million (US$2.5 million) through the sale of 682,500 sh...